Faeth Therapeutics FTH
NASDAQ FTH
$39.00 +2.88 (+7.97%)
As of: Sep 10, 2026 · 3:59 PM EDT

Faeth Therapeutics (FTH) Debt Ratio (2020 - 2021)

Faeth Therapeutics' (FTH) quarterly Debt Ratio came in at 0.0 in Q2 2021, up 4.03% quarter-over-quarter from 0.0 in Q1 2021.

Analysis

Faeth Therapeutics (FTH) Debt Ratio (2020 - 2021) Analysis & Trends

Faeth Therapeutics (FTH) has reported Debt Ratio for 2 consecutive years, with 0.0 the latest figure, recorded in Q2 2021.

  • For the quarter ending Q2 2021, Debt Ratio changed N/A year-over-year to 0.0; the trailing twelve-month figure through Jun 2021 stood at 0.0 (changed N/A YoY), and the FY2020 full-year result was 0.03, changed N/A from the prior year.
  • Debt Ratio improved to 0.0 in Q2 2021 per FTH's latest filing, from 0.0 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.03 in Q4 2020 and bottomed at 0.0 in Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 0.66
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 0.58
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 0.05
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 0.05
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 0.25
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Faeth Therapeutics 218.99 Mn 218.99 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 0.00
Mar 31, 2021 0.00
Dec 31, 2020 0.03